Association of interferon-gamma and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • B. Z. Alizadeh - (Author)
  • P. Hanifi-Moghaddam - (Author)
  • P. Eerligh - (Author)
  • A. R. van der Slik - (Author)
  • H. Kolb - (Author)
  • A. V. Kharagjitsingh - (Author)
  • A. M. Pereira Arias - (Author)
  • M. Ronkainen - (Author)
  • M. Knip - (Author)
  • R. Bonfanti - (Author)
  • E. Bonifacio - , Chair of Preclinical stem cell therapy and diabetes (Author)
  • D. Devendra - (Author)
  • T. Wilkin - (Author)
  • M. J. Giphart - (Author)
  • B. P. C. Koeleman - (Author)
  • R. Nolsoe - (Author)
  • T. Mandrup Poulsen - (Author)
  • N. C. Schloot - (Author)
  • B. O. Roep - (Author)

Details

Original languageEnglish
Pages (from-to)480-484
JournalClinical and experimental immunology
Volume145
Issue number3
Publication statusPublished - Sept 2006
Peer-reviewedYes

External IDs

Scopus 33747392476
ORCID /0000-0002-8704-4713/work/141544340

Keywords

Sustainable Development Goals

Keywords

  • clinical remission, disease marker, IFN-gamma, IL-10, prediction, type 1 diabetes